83 3 Responses of alveolar-like macrophages to lysine deacetylase inhibition REFERENCES 1. Mould KJ, Barthel L, Mohning MP, Thomas SM, McCubbrey AL, Danhorn T, Leach SM, Fingerlin TE, O’Connor BP, Reisz JA, et al. Cell Origin Dictates Programming of Resident versus Recruited Macrophages during Acute Lung Injury. Am J Respir Cell Mol Biol (2017) 57:294–306. doi: 10.1165/rcmb.2017-0061OC 2. Li X, Kolling FW, Aridgides D, Mellinger D, Ashare A, Jakubzick C v, Jakubzick C. ScRNA-seq Expression of IFI27 and APOC2 Identifies Four Alveolar Macrophage Superclusters in Healthy BALF. bioRxiv (2022)2022.01.30.478325. doi: 10.1101/2022.01.30.478325 3. Branchett WJ, Cook J, Oliver RA, Bruno N, Walker SA, Stölting H, Mack M, O’Garra A, Saglani S, Lloyd CM. Airway macrophage-intrinsic TGF-β1 regulates pulmonary immunity during earlylife allergen exposure. Journal of Allergy and Clinical Immunology (2021) 147:1892–1906. doi: 10.1016/J.JACI.2021.01.026 4. Mould KJ, Jackson ND, Janssen WJ. Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets. JCI Insight (2019) 4:126556. doi: 10.1172/jci.insight.126556 5. Viola A, Munari F, Sánchez-Rodríguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol (2019) 10:1462. doi: 10.3389/fimmu.2019.01462 6. Woods PS, Kimmig LM, Meliton AY, Sun KA, Tian Y, O’Leary EM, Gökalp GA, Hamanaka RB, Mutlu GM. Tissue-resident alveolar macrophages do not rely on glycolysis for LPS-induced inflammation. Am J Respir Cell Mol Biol (2020) 62:243–255. doi: 10.1165/RCMB.2019-0244OC 7. Boorsma CE, Draijer C, Melgert BN. Macrophage Heterogeneity in Respiratory Diseases. Mediators Inflamm (2013) 2013:1–19. doi: 10.1155/2013/769214 8. Aegerter H, Lambrecht BN, Jakubzick C v. Biology of lung macrophages in health and disease. Immunity (2022) 55:1564–1580. doi: 10.1016/j.immuni.2022.08.010 9. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med (2022) 10:447–458. doi: 10.1016/ S2213-2600(21)00511-7 10. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Am J Respir Crit Care Med (2017) 195:557–582. doi: 10.1164/RCCM.201701-0218PP 11. Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner C. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. European Respiratory Journal (1998) 12:380–386. doi: 10.1183/09031936.98.12020380. 12. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (2012) 153:530–534. doi: 10.1164/AJRCCM.153.2.8564092 13. Branchett WJ, Lloyd CM. Regulatory cytokine function in the respiratory tract. Mucosal Immunol (2019) 12:589–600. doi: 10.1038/s41385-019-0158-0 14. Ehrchen JM, Roth J, Barczyk-Kahlert K. More than suppression: Glucocorticoid action on monocytes and macrophages. Front Immunol (2019) 10: doi: 10.3389/fimmu.2019.02028 15. Barczyk K, Ehrchen J, Tenbrock K, Ahlmann M, Kneidl J, Viemann D, Roth J. Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. Blood (2010) 116:446–455. doi: 10.1182/BLOOD-2009-10-247106
RkJQdWJsaXNoZXIy MTk4NDMw